Latest return on equity
Enliven Therapeutics Return on equity
Direct answer
Enliven Therapeutics's return on equity is -15.31%.
The verified market snapshot reports -15.31%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 27, 2026.
Get free Enliven Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -15.31%
Explore related company data
View Enliven Therapeutics's market capitalizationView Enliven Therapeutics's price-to-book ratioView Enliven Therapeutics's dividend yieldView Enliven Therapeutics's 52-week price rangeView Enliven Therapeutics's profit marginView Enliven Therapeutics's debt-to-equity ratioView all Enliven Therapeutics key metricsReturn to Enliven Therapeutics profile